Key Metrics
CiteScore 

4.8
Impact Factor 

< 5
Scite Index 

0.82 5-Year SI

SJR 

Q2Infectious Diseases

SNIP 

1.45
Recommended pre-submission checks
Powered by 

Topics Covered on BMC Infectious Diseases
BMC Infectious Diseases Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | BMC |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | EUR 2290 | USD 2690 | GBP 2090 |
| Publication Time | 21 |
| Editorial Review Process | Open peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2001 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC0 |
| OA statement | Visit website |
View less
Planning to publish in BMC Infectious Diseases ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in BMC Infectious Diseases
The precision of behavioral intervention strategies remain one of the key strategies for HIV prevention among MSM in the era of pharmaceutical interventions: an ecological study.
- 29 Oct 2025
- BMC infectious diseases
Analysis of a rare case of vaginitis caused by Trichomonas vaginalis combined with fungal infection.
- 29 Oct 2025
- BMC infectious diseases
Seroprevalence of Immunoglobulin M and G antibodies to severe acute respiratory syndrome coronavirus 2 infection in Iwo, Nigeria.
- 29 Oct 2025
- BMC infectious diseases
Correlates of virological non-suppression among children and adolescents aged 5-19 years on Dolutegravir-based regimens attending Gulu regional referral hospital, Northern Uganda: a mixed methods cross-sectional study.
- 29 Oct 2025
- BMC infectious diseases
Efficacy and safety of echinocandins combined with Trimethoprim-Sulfamethoxazole as first-line treatment for Pneumocystis pneumonia in HIV-infected and non-HIV-infected patients.
- 29 Oct 2025
- BMC infectious diseases
Emerging Neisseria meningitidis ST-1466 and ST-11026 as urogenital pathogens in China.
- 29 Oct 2025
- BMC infectious diseases
The precision of behavioral intervention strategies remain one of the key strategies for HIV prevention among MSM in the era of pharmaceutical interventions: an ecological study.
- 29 Oct 2025
- BMC infectious diseases
Analysis of a rare case of vaginitis caused by Trichomonas vaginalis combined with fungal infection.
- 29 Oct 2025
- BMC infectious diseases
Seroprevalence of Immunoglobulin M and G antibodies to severe acute respiratory syndrome coronavirus 2 infection in Iwo, Nigeria.
- 29 Oct 2025
- BMC infectious diseases
Correlates of virological non-suppression among children and adolescents aged 5-19 years on Dolutegravir-based regimens attending Gulu regional referral hospital, Northern Uganda: a mixed methods cross-sectional study.
- 29 Oct 2025
- BMC infectious diseases
Efficacy and safety of echinocandins combined with Trimethoprim-Sulfamethoxazole as first-line treatment for Pneumocystis pneumonia in HIV-infected and non-HIV-infected patients.
- 29 Oct 2025
- BMC infectious diseases
Emerging Neisseria meningitidis ST-1466 and ST-11026 as urogenital pathogens in China.
- 29 Oct 2025
- BMC infectious diseases